A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) on Monday, as the share price of these exchange-traded funds were up around 1% in the day’s session. Their share prices have greatly improved over the past year.

Specifically, ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 4,512,926 shares of the special purpose acquisition company (SPAC), and ARK Innovation ETF (NYSEARCA: ARKK) bought 2,506,461 shares. At Monday’s closing prices, this would have valued this purchase at roughly $70.2 million. This is only a small fraction of the total holdings. ARKG is up 57% over the past 52 weeks and ARKK is up 54%.

Here is a quick look at all the purchases made by ARK ETFs:

Fund	Ticker	Company	Shares
ARKG	ADPT	Adaptive Biotechnologies	232,610
ARKG	SRNG	Soaring Eagle Acquisition	4,512,926
ARKG	SGFY	Signify Health	30,490
ARKK	Z	Zillow	101,994
ARKK	TSP	TuSimple	316,814
ARKK	SRNG	Soaring Eagle Acquisition	2,506,461
ARKQ	MKFG	Markforged	57,406
ARKQ	PATH	UiPath	8,178
ARKW	LPSN	LivePerson	22,696
ARKW	Z	Zillow	24,750
ARKW	PATH	UiPath	8,641
ARKX	BLDE	Blade Air Mobility	16,370
ARKX	KTOS	Kratos Defense & Security Solutions	49,634

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.